Researchers

NAKAGAWA Kazuhiko

NAKAGAWA Kazuhiko
Specially Appointed Professor
Faculty Department of Medicine
Researchmap https://researchmap.jp/Nakagawa_Kazuhiko

Education and Career

Education

  • - 1983 , Kumamoto University, Faculty of Medicine,
  • - 1983 , Kumamoto University, School of Medicine,

Research Activities

Research Areas

  • Life sciences, Respiratory medicine

Research Interests

臨床腫瘍学, Medical Oncology

Published Papers

  1. Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
    Hidetoshi Hayashi; Kenji Chamoto; Ryusuke Hatae; Takashi Kurosaki; Yosuke Togashi; Kazuya Fukuoka; Megumi Goto; Yasutaka Chiba; Shuta Tomida; Takayo Ota; Koji Haratani; Takayuki Takahama; Junko Tanizaki; Takeshi Yoshida; Tsutomu Iwasa; Kaoru Tanaka; Masayuki Takeda; Tomoko Hirano; Hironori Yoshida; Hiroaki Ozasa; Yuichi Sakamori; Kazuko Sakai; Keiko Higuchi; Hitoshi Uga; Chihiro Suminaka; Toyohiro Hirai; Kazuto Nishio; Kazuhiko Nakagawa; Tasuku Honjo
    Journal of Clinical Investigation  134  (7)  1, Apr. 2024 
  2. Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
    Koji Haratani; Atsushi Nakamura; Nobuaki Mamesaya; Kenji Sawa; Yoshimasa Shiraishi; Ryota Saito; Junko Tanizaki; Yosuke Tamura; Akito Hata; Kosuke Tsuruno; Tomohiro Sakamoto; Shunsuke Teraoka; Masahide Oki; Hiroshi Watanabe; Takaaki Tokito; Kenji Nagata; Takeshi Masuda; Yasushi Nakamura; Kazuko Sakai; Yasutaka Chiba; Akihiko Ito; Kazuto Nishio; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Hidetoshi Hayashi
    British journal of cancer  22, Mar. 2024 
  3. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
    Yoshimasa Shiraishi; Junji Kishimoto; Shunichi Sugawara; Hideaki Mizutani; Haruko Daga; Koichi Azuma; Hirotaka Matsumoto; Osamu Hataji; Kazumi Nishino; Masahide Mori; Takehito Shukuya; Haruhiro Saito; Motoko Tachihara; Hidetoshi Hayashi; Asuka Tsuya; Kazushige Wakuda; Noriko Yanagitani; Tomohiro Sakamoto; Satoru Miura; Akito Hata; Morihito Okada; Toshiyuki Kozuki; Yuki Sato; Taishi Harada; Koichi Takayama; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Isamu Okamoto
    JAMA oncology  21, Dec. 2023 

MORE

Books etc

  1. 入門腫瘍内科学 , 西條 長宏; 中川 和彦; 西尾 和人; 荒尾 徳三; 石岡 千加史; 田村 和夫; 南 博信; 古瀬 純司; 赤座 英之; 中西 洋一; 木浦 勝行 , 篠原出版新社 , 2009

Conference Activities & Talks

  1. WJOGの現状と今後の展望 , 中川和彦; 武田晃司; 室 圭; 高野利実; 山本信之 , 第94回日本胃癌学会総会 , 4, Mar. 2022
  2. Distinctive characteristics MSI-H in chemo;immune therapy for gastric cancer , Hisato Kawakami; Kei Muro; Kazuhiko Nakagawa , 第94回日本胃癌学会総会 , 3, Mar. 2022
  3. FOLRα positive gastric cancer exhibits chemorisistance that is overcome by a novel ADC,MoRAb-202 , Hisato Kawakami; Hitomi Sakai; Tekashi Teramura; Yuuta Onodera; Erizabeth Somers; Keiji Furuuchi; Yoshimitsu Uenaka; Ryoji Kato; Kazuhiko Nakagawa , 第94回日本胃癌学会総会 , 3, Mar. 2022

MORE

MISC

  1. 完全切除後II-III期のEGFR変異陽性非小細胞肺癌に対する第III相IMPACT試験における付随バイオマーカー研究 , 庄田 浩康; 池田 慧; 坪井 正博; 坂井 和子; 三角 俊裕; 赤松 弘朗; 棚橋 雅幸; 丹保 裕一; 齋藤 春洋; 豊岡 伸一; 井野川 英利; 芳川 豊史; 横山 俊秀; 岡本 龍郎; 柳谷 典子; 沖 昌英; 光冨 徹哉; 多田 弘人; 中川 和彦; 西尾 和人 , 肺癌 , 63 , 5 , 499 , 499 , Oct. 2023
  2. PTPRRを介したEGFR活性化に起因するKRASG12C阻害薬耐性の克服(Combating acquired resistance to KRAS inhibitors in NSCLC by targeting PTPRR-mediated activation of EGFR signaling) , 金村 宙昌; 竹原 俊幸; 小野寺 勇太; 寺村 岳士; 鈴木 慎一郎; 坂井 和子; 西尾 和人; 中川 和彦; 林 秀敏; 米阪 仁雄 , 日本癌学会総会記事 , 82回 , 422 , 422 , Sep. 2023
  3. Comparing morphine with oxycodone for cancer pain using a catechol-O-methyltransferase genotype biomarker (RELIEF study): A randomized clinical trial , 阪本亮; 阪本亮; 松岡弘道; 鶴谷純司; 千葉康敬; 藤田至彦; 酒井清裕; 吉田健史; 吉田健史; 名倉美樹; 大武陽一; 小山敦子; 小山敦子; 西尾和人; 中川和彦 , 日本心身医学会総会ならびに学術講演会抄録集 , 64th , 2023

MORE

Patents

  1. 非小細胞肺癌に対する化学療法の治療効果予測方法 , 中川 和彦, 萩本啓文

Awards & Honors

  1. 1997, 米国臨床腫瘍学会トラベルアワード(ASCO)
  2. 1996, 米国癌学会トラベルアワード(AACR)
  3. 1988, 米国臨床腫瘍学会トラベルアワード(ASCO)

Research Grants & Projects

  1. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, A biomarker study of heregulin to predict efficacy of anti-HER2 drugs in HER2-positive breast and gastric cancer , Kindai University
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Antitumor Action of the MET Tyrosine Kinase Inhibitor in Gastric Cancer Positive for MET Amplification
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Multiplex molecular profiling in advanced non-small cell lung cancers

MORE